Pembrolizumab-induced lichen planus pemphigoides in a patient with metastatic Merkel cell carcinoma by Chase W. Kwon, MD, Rajini K. Murthy, MD, Ragini Kudchadkar, MD, Benjamin K. Stoff, MD, MA

Get full text

A phase IB study of ipilimumab with peginterferon alfa-2b in patients with unresectable melanoma by Joseph Markowitz, Ragini Kudchadkar, Jeffrey S. Weber, Zeynep Eroglu, Andrew S. Brohl, Nikhil I. Khushalani, Ram Thapa, Y. Ann Chen

Get full text

FcγRIIB is a T cell checkpoint in antitumor immunity by Clara R. Farley, Anna B. Morris, Marvi Tariq, Kelsey B. Bennion, Sayalee Potdar, Ragini Kudchadkar, Michael C. Lowe, Mandy L. Ford

Get full text

Real-world assessment and treatment of locally advanced basal cell carcinoma: Findings from the RegiSONIC disease registry by Aleksandar Sekulic, Simon Yoo, Ragini Kudchadkar, Julie Guillen, Gary Rogers, Anne Lynn S. Chang, Scott Guenthner, Bernard Raskin, Keith Dawson, Yong Mun, Laura Chu, Edward McKenna, Mario Lacouture

Get full text

Real-world assessment and treatment of locally advanced basal cell carcinoma: Findings from the RegiSONIC disease registry. by Aleksandar Sekulic, Simon Yoo, Ragini Kudchadkar, Julie Guillen, Gary Rogers, Anne Lynn S Chang, Scott Guenthner, Bernard Raskin, Keith Dawson, Yong Mun, Laura Chu, Edward McKenna, Mario Lacouture

Get full text

Case Report: Delayed Onset Multi-Organ Toxicities in a Melanoma Patient Achieving Complete Response to BRAF/MEK Inhibition by Hannah M. Knochelmann, Hannah M. Knochelmann, Michael Brandon Ware, Aditya Rali, Susanne Linderman, Susanne Linderman, Jessica G. Shantha, David H. Lawson, Melinda Yushak, Robert Swerlick, Chrystal M. Paulos, Steven Yeh, Steven Yeh, Ragini Kudchadkar

Get full text

629 Neoadjuvant SEMA4D inhibitor pepinemab combination with nivolumab increases crosstalk between B cell and CD26hi T cell in patients with resectable stage III melanoma by Brian Burns, Elizabeth Evans, Ragini Kudchadkar, Crystal Mallow, Christine Reilly, Maurice Zauderer, Gregory B Lesinski, Keith A Delman, Chrystal M Paulos, Brian Olson, Terrence Fisher, Jayden Kim, Michael C Lowe, Ayana T Ruffin, Jacklyn Hammons, Agnes Harutyunyan, Melinda Yushak, Ali Mokhtari, Douglas Parker

547 CERPASS: A randomized, controlled, open-label, phase 2 study of cemiplimab ± RP1 in patients with advanced cutaneous squamous cell carcinoma by Andrew Haydon, Celeste Lebbe, Jose Lutzky, Gregory Daniels, Ragini Kudchadkar, Ann Silk, Nikhil Khushalani, Frances Collichio, Jean-Jaques Grob, Samantha Bowyer, Praveen Bommareddy, Andrew Hill, Danny Rischin, Daniel Brungs, Michael Migden, Matthew Fury, Jenny Lee, Muhammad Alamgeer, Dimitrios Colevas, Wanxing Chai-Ho, Piyush Sheladia, Shui He, Claudia Andreu-Vieyra

Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanoma by Judith D Goldberg, Joseph Markowitz, Jeffrey Weber, Ragini Kudchadkar, Tomas Kirchhoff, Anna Pavlick, Zeynep Eroglu, Melinda Vassallo, David M Woods, Andrew S Brohl, Nikhil I Khushalani, Alison Richards, Younchul Kim, Biwei Cao, Robert Ferguson, Kelsey R Monson, Carol M Amato, Paulo Burke, Ann Strange, Emily Monk, Geoffrey Thomas Gibney

Get full text

Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy by Mehmet Asim Bilen, Julie M. Shabto, Dylan J. Martini, Yuan Liu, Colleen Lewis, Hannah Collins, Mehmet Akce, Haydn Kissick, Bradley C. Carthon, Walid L. Shaib, Olatunji B. Alese, Conor E. Steuer, Christina Wu, David H. Lawson, Ragini Kudchadkar, Viraj A. Master, Bassel El-Rayes, Suresh S. Ramalingam, Taofeek K. Owonikoko, R. Donald Harvey

Get full text